國立高雄大學圖資館 |

語系: 繁體中文

說明(常見問題)

圖資館首頁

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Diagnosis and treatment of pulmonary...

Fukumoto, Yoshihiro.

Diagnosis and treatment of pulmonary hypertensionfrom bench to bedside /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Diagnosis and treatment of pulmonary hypertensionedited by Yoshihiro Fukumoto.
其他題名:	from bench to bedside /
其他作者:	Fukumoto, Yoshihiro.
出版者:	Singapore :Springer Singapore :2017.
面頁冊數:	viii, 236 p. :ill. (some col.), digital ;24 cm.
Contained By:	Springer eBooks
標題:	Pulmonary hypertensionDiagnosis.
電子資源:	http://dx.doi.org/10.1007/978-981-287-840-3
ISBN:	9789812878403$q(electronic bk.)

Diagnosis and treatment of pulmonary hypertensionfrom bench to bedside /
Diagnosis and treatment of pulmonary hypertensionfrom bench to bedside /[electronic resource] :edited by Yoshihiro Fukumoto. - Singapore :Springer Singapore :2017. - viii, 236 p. :ill. (some col.), digital ;24 cm.

Part I Fundamentals of Pulmonary Hypertension -- 1.Clinical Classification -- 2.Diagnosis - Imagings -- Part II Pathophysiology and Genetics -- 3.Pathogenic and Therapeutic Role of MicroRNA in Pulmonary Arterial Hypertension -- 4.Sex Hormones -- 5.Rho-Kinase -- 6.The Unique Property of the Pulmonary Artery Regard-ing the Smooth Muscle Effects of Proteinase-activated Receptor 1 - The Possible Contribution to the Pathogenesis of Pulmonary Hypertension -- 7. Animal Models with Pulmonary Hypertension -- 8.Human Pathology -- 9. Pathophysiology and Genetics: BMPR2 -- Part III Treatment of Pulmonary Arterial Hypertension (PAH) -- 10. Prostacyclin -- 11. Targeting the NO-sGC-cGMP pathway in pulmonary arterial hypertension -- 12. Endothelin Receptor Antagonist -- 13. LUNG TRANSPLANTATION -- Part IV Treatment of Chronic Thromboembolic Pulmonary Hypertension (CTEPH) -- 14. Medical Therapy for Chronic Thromboembolic Pulmonary Hypertension -- 15. Balloon Pulmonary Angioplasty -- 16. Pulmonary Endarterectomy for Chronic Thromboembolic Pulmonary Hypertension -- Part V Right Ventricular Function -- 17. Right Ventricular Function.

This book focuses on pulmonary arterial hypertension (PAH, Group 1) and chronic thromboembolic pulmonary hypertension (CTEPH, Group 4) among the various groups of pulmonary hypertension (PH) whose classification was updated into five major categories at the 5th World Symposium held in Nice, France, in 2013. Readers will find recent progress, methods, and up-to-date information on PH mechanisms, diagnostic images, and treatment in the management of PH. This volume, with contributions by leading researchers worldwide in the field , consists of five parts, starting with the fundamentals of PH, then pathophysiology and genetics, treatment, and right ventricular function.

ISBN: 9789812878403$q(electronic bk.)

Standard No.: 10.1007/978-981-287-840-3doiSubjects--Topical Terms:

773292
Pulmonary hypertension
--Diagnosis.

LC Class. No.: RC776.P87

Dewey Class. No.: 616.24

Diagnosis and treatment of pulmonary hypertensionfrom bench to bedside /
LDR:02775nmm a2200313 a 4500 001 506951
003 DE-He213
005 20170816151434.0
006 m d
007 cr nn 008maaau
008 171030s2017 si s 0 eng d
020 $a 9789812878403$q(electronic bk.)
020 $a 9789812878397$q(paper)
024 7 $a 10.1007/978-981-287-840-3 $2 doi
035 $a 978-981-287-840-3
040 $a GP $c GP
041 0 $a eng
050 4 $a RC776.P87
072 7 $a MJD $2 bicssc
072 7 $a MED010000 $2 bisacsh
082 0 4 $a 616.24 $2 23
090 $a RC776.P87 $b D536 2017
245 0 0 $a Diagnosis and treatment of pulmonary hypertension $h [electronic resource] : $b from bench to bedside / $c edited by Yoshihiro Fukumoto.
260 $a Singapore : $b Springer Singapore : $b Imprint: Springer, $c 2017.
300 $a viii, 236 p. : $b ill. (some col.), digital ; $c 24 cm.
505 0 $a Part I Fundamentals of Pulmonary Hypertension -- 1.Clinical Classification -- 2.Diagnosis - Imagings -- Part II Pathophysiology and Genetics -- 3.Pathogenic and Therapeutic Role of MicroRNA in Pulmonary Arterial Hypertension -- 4.Sex Hormones -- 5.Rho-Kinase -- 6.The Unique Property of the Pulmonary Artery Regard-ing the Smooth Muscle Effects of Proteinase-activated Receptor 1 - The Possible Contribution to the Pathogenesis of Pulmonary Hypertension -- 7. Animal Models with Pulmonary Hypertension -- 8.Human Pathology -- 9. Pathophysiology and Genetics: BMPR2 -- Part III Treatment of Pulmonary Arterial Hypertension (PAH) -- 10. Prostacyclin -- 11. Targeting the NO-sGC-cGMP pathway in pulmonary arterial hypertension -- 12. Endothelin Receptor Antagonist -- 13. LUNG TRANSPLANTATION -- Part IV Treatment of Chronic Thromboembolic Pulmonary Hypertension (CTEPH) -- 14. Medical Therapy for Chronic Thromboembolic Pulmonary Hypertension -- 15. Balloon Pulmonary Angioplasty -- 16. Pulmonary Endarterectomy for Chronic Thromboembolic Pulmonary Hypertension -- Part V Right Ventricular Function -- 17. Right Ventricular Function.
520 $a This book focuses on pulmonary arterial hypertension (PAH, Group 1) and chronic thromboembolic pulmonary hypertension (CTEPH, Group 4) among the various groups of pulmonary hypertension (PH) whose classification was updated into five major categories at the 5th World Symposium held in Nice, France, in 2013. Readers will find recent progress, methods, and up-to-date information on PH mechanisms, diagnostic images, and treatment in the management of PH. This volume, with contributions by leading researchers worldwide in the field , consists of five parts, starting with the fundamentals of PH, then pathophysiology and genetics, treatment, and right ventricular function.
650 0 $a Pulmonary hypertension $x Diagnosis. $3 773292
650 0 $a Pulmonary hypertension $x Treatment. $3 773293
650 1 4 $a Medicine & Public Health. $3 273799
650 2 4 $a Cardiology. $3 273804
650 2 4 $a Pneumology/Respiratory System. $3 274253
650 2 4 $a Cardiac Surgery. $3 275925
700 1 $a Fukumoto, Yoshihiro. $3 773291
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
856 4 0 $u http://dx.doi.org/10.1007/978-981-287-840-3
950 $a Medicine (Springer-11650)